MEDICAL & BIOLOGICAL LABORATORIES CO.,LTD. 4557Short Interest
No institution currently reports a short position of 0.5% or more in MEDICAL & BIOLOGICAL LABORATORIES CO.,LTD. (4557). The last disclosure was on 2020-10-09 (Credit Suisse AG, 0.45%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
84 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 5 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2019-10-11 |
|---|---|
| Latest disclosure | 2020-10-09 (Credit Suisse AG, 0.45%) |
| Reporting institutions | 7 firms (84 reports) |
| Peak estimated short interest | 1.65% (2020-02-18, 2 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
No position of 0.5% or more reported within a year existed in the last 5 years, so no chart is shown. Past disclosures are listed in the tables below.
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2020-03-16 | JPM Securities Japan Co Ltd. | Position 24,979 shares | Ratio 0.47% | ▼0.06% | Below 0.5% |
| 2020-10-09 | Credit Suisse AG | Position 23,800 shares | Ratio 0.45% | ▼0.08% | Below 0.5% |
| 2019-10-31 | Credit Suisse Securities (Europe) Limited | Position 21,800 shares | Ratio 0.41% | ▼0.28% | Below 0.5% |
| 2020-01-15 | GOLDMAN SACHS INTERNATIONAL | Position 19,822 shares | Ratio 0.38% | ▼0.18% | Below 0.5% |
| 2020-08-03 | Morgan Stanley MUFG Securities Co., Ltd. | Position 20,000 shares | Ratio 0.38% | ▼0.12% | Below 0.5% |
| 2019-12-24 | J.P. MORGAN SECURITIES PLC | Position 0 shares | Ratio 0.00% | ▼0.62% | Closed |
| 2020-01-21 | Morgan Stanley & Co. International plc | Position 0 shares | Ratio 0.00% | ▼0.53% | Closed |
Disclosure History 84 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2020-10-09 | Credit Suisse AG | Position 23,800 shares | Ratio 0.45% | ▼0.08% | Below 0.5% |
| 2020-10-05 | Credit Suisse AG | Position 27,700 shares | Ratio 0.53% | ▼0.07% | — |
| 2020-09-30 | Credit Suisse AG | Position 31,300 shares | Ratio 0.60% | ▲0.21% | — |
| 2020-09-18 | Credit Suisse AG | Position 23,100 shares | Ratio 0.44% | ▼0.24% | Below 0.5% |
| 2020-09-17 | Credit Suisse AG | Position 35,800 shares | Ratio 0.68% | ▼0.10% | — |
| 2020-09-09 | Credit Suisse AG | Position 40,700 shares | Ratio 0.78% | ▼0.02% | — |
| 2020-09-07 | Credit Suisse AG | Position 42,200 shares | Ratio 0.80% | ▲0.01% | — |
| 2020-09-02 | Credit Suisse AG | Position 41,600 shares | Ratio 0.79% | ▼0.03% | — |
| 2020-08-27 | Credit Suisse AG | Position 43,000 shares | Ratio 0.82% | ▲0.03% | — |
| 2020-08-26 | Credit Suisse AG | Position 41,600 shares | Ratio 0.79% | ▼0.02% | — |
| 2020-08-20 | Credit Suisse AG | Position 42,300 shares | Ratio 0.81% | ▲0.02% | — |
| 2020-08-19 | Credit Suisse AG | Position 41,400 shares | Ratio 0.79% | ▼0.04% | — |
| 2020-08-06 | Credit Suisse AG | Position 43,700 shares | Ratio 0.83% | ▲0.05% | — |
| 2020-08-05 | Credit Suisse AG | Position 41,000 shares | Ratio 0.78% | ▼0.02% | — |
| 2020-08-03 | Credit Suisse AG | Position 41,800 shares | Ratio 0.80% | ▲0.02% | — |
| 2020-08-03 | Morgan Stanley MUFG Securities Co., Ltd. | Position 20,000 shares | Ratio 0.38% | ▼0.12% | Below 0.5% |
| 2020-07-31 | Morgan Stanley MUFG Securities Co., Ltd. | Position 26,200 shares | Ratio 0.50% | ▼0.10% | — |
| 2020-07-30 | Credit Suisse AG | Position 41,000 shares | Ratio 0.78% | ▲0.18% | — |
| 2020-07-30 | Morgan Stanley MUFG Securities Co., Ltd. | Position 31,300 shares | Ratio 0.60% | ▼0.12% | — |
| 2020-07-29 | Credit Suisse AG | Position 31,400 shares | Ratio 0.60% | ▲0.55% | — |
| 2020-07-29 | Morgan Stanley MUFG Securities Co., Ltd. | Position 37,900 shares | Ratio 0.72% | ▲0.27% | — |
| 2020-07-14 | Credit Suisse AG | Position 18,500 shares | Ratio 0.35% | ▼0.25% | Below 0.5% |
| 2020-07-09 | Credit Suisse AG | Position 31,700 shares | Ratio 0.60% | ▲0.08% | — |
| 2020-07-07 | Credit Suisse AG | Position 27,600 shares | Ratio 0.52% | ▲0.07% | — |
| 2020-03-16 | JPM Securities Japan Co Ltd. | Position 24,979 shares | Ratio 0.47% | ▼0.06% | Below 0.5% |
| 2020-03-13 | JPM Securities Japan Co Ltd. | Position 27,679 shares | Ratio 0.53% | ▼0.11% | — |
| 2020-03-12 | JPM Securities Japan Co Ltd. | Position 33,679 shares | Ratio 0.64% | ▼0.08% | — |
| 2020-03-11 | Credit Suisse AG | Position 25,400 shares | Ratio 0.48% | ▼0.05% | Below 0.5% |
| 2020-03-10 | JPM Securities Japan Co Ltd. | Position 37,579 shares | Ratio 0.72% | ▼0.11% | — |
| 2020-03-10 | Credit Suisse AG | Position 27,800 shares | Ratio 0.53% | ▼0.15% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| SEIKAGAKU CORPORATION4548 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| EIKEN CHEMICAL CO.,LTD.4549 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| JCR Pharmaceuticals Co.,Ltd.4552 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| TOWA PHARMACEUTICAL CO.,LTD.4553 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| Fuji Pharma Co.,Ltd.4554 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| CHUKYO IYAKUHIN CO.,LTD.4558 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| ZERIA PHARMACEUTICAL CO.,LTD.4559 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| AnGes,Inc.4563 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| OncoTherapy Science,Inc.4564 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Nxera Pharma Co.,Ltd.4565 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |